Palivizumab Following Extremely Premature Birth Does Not Affect Pulmonary Outcomes in Adolescence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Palivizumab Following Extremely Premature Birth Does Not Affect Pulmonary Outcomes in Adolescence

Published:2020-08 Issue:2 Volume:158 Page:660-669
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Amitai Nofar,Stafler Patrick,Blau Hannah,Kaplan Eytan,Mussaffi Huda,Levine Hagit,Steuer Guy,Bar-Yishay Ephraim,Klinger Gil,Mei-Zahav Meir,Prais Dario

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference35 articles.

1. Airway function measurements and the long- term follow- up of survivors of preterm birth with and without chronic lung disease;Narang;Pediatr Pulmonol,2006

2. Association between asthma and lung function in adolescents born very preterm: results of the EPIPAGE cohort study;Hadchouel;Thorax,2018

3. Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the postsurfactant era;Kaplan;Chest,2012

4. Effect of preterm birth on later FEV1: a systematic review and meta-analysis;Kotecha;Thorax,2013

5. Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health;O’Reilly;Clin Exp Pharmacol Physiol,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiopulmonary exercise testing in adolescence following extremely premature birth;Pediatric Pulmonology;2024-01-19

2. Respiratory Syncytial Virus Prophylaxis With Palivizumab Is Not Associated With Improved Lung Function in Infants of Very Low Birth Weight at Early School Age;CHEST Pulmonary;2023-11

3. Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease;Drug, Healthcare and Patient Safety;2023-09

4. Einfluss der RSV-Prophylaxe mit Palivizumab bei VLBW-Frühgeborenen auf die Lungenfunktion im Alter von 5 Jahren;Zeitschrift für Geburtshilfe und Neonatologie;2023-06

5. New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus;Infection and Drug Resistance;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3